Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019)

Sanchez-Martinez, C; Lallena, MJ; Sanfeliciano, SG; de Dios, A

Sanchez-Martinez, C (reprint author), Eli Lilly & Co, Discovery Chem Res & Technol, Alcobendas 28108, Madrid, Spain.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019; 29 (20):

Abstract

Sustained proliferative capacity and gene dysregulation are hallmarks of cancer. In mammalian cells, cyclin-dependent kinases (CDKs) control critical ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索